San Diego-based mostly Viking Therapeutics marked alone as a serious competitor while in the weight loss drug current market in February right after revealing promising knowledge from the mid-stage demo of experimental drug VK2735, which suggested it rivaled—and outperformed—Novo and Lilly drugs when presented for a weekly injection As well as